NorthX Biologics News and Resources

Amarna Therapeutics has entered into a formal agreement with NorthX Biologics to support the continued development and manufacturing of Nimvec™ AM510, a gene therapy candidate aimed at treating Type 1 Diabetes (T1D). The agreement follows a previously announced strategic partnership between the two

Amarna Therapeutics, a biotechnology company focused on transformative gene therapies, has announced a strategic partnership with NorthX Biologics, a company focused on biologics manufacturing. The collaboration will facilitate the development of Nimvec AM510, a gene therapy designed to treat immune-mediated